Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Arena Pharmaceuticals, Inc. published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 14
» View latimes.com items only
    Jun 27, 2012 |Story| Los Angeles Times

  1. FDA approves lorcaserin, first weight-loss drug since 1999

    The Food and Drug Administration has approved marketing of the weight-loss drug lorcaserin, the first prescription anti-obesity medication to win the FDA's blessing since the agency approved orlistat in 1999.
    The Food and Drug Administration has approved marketing of the weight-loss drug lorcaserin, the first prescription anti-obesity medication to win the FDA's blessing since the agency approved orlistat in 1999. Once it is cleared by the Drug Enforcement...

    Tags: Obesity, Cancer, Heart Disease, Diabetes, High Blood Pressure

    2. Oct 25, 2010 |Story| Los Angeles Times

  2. FDA shoots down another weight loss drug [Updated]

    The FDA has <a title="Arena Pharmaceuticals' press release" href="http://invest.arenapharm.com/releasedetail.cfm?ReleaseID=521977" target="_blank">told the makers</a> of the proposed weight-loss drug Lorcaserin&nbsp;that it will not&nbsp;at this time approve the marketing of &nbsp;the medication, citing concerns about its marginal effectiveness and about&nbsp;cancers that occurred at higher-than-usual rates in animal studies. [<b>Updated Oct. 25, 10:35 a.m.</b> An earlier version of this article said cancers occurred at higher-than-usual-rates during clinical trials.]
    The FDA has told the makers of the proposed weight-loss drug Lorcaserin that it will not at this time approve the marketing of  the medication, citing concerns about its marginal effectiveness and about cancers that occurred at higher-than-usual rates...

    Tags: Crime, Law and Justice, Health, Health and Medical Professionals, Obesity, Human Body

    3. Oct 28, 2009 | Los Angeles Times

  3. Obesity drugs lumber toward marketplace

    Booster Shots
    About this time last year, we were reporting on the failure of several investigational weight-loss medications. They included Sanofi-Aventis' rimonabant as well as two other drugs that aimed to work by blocking cannabinoid receptors in the brain. However,...
    4. Jun 28, 2012 |Story| KTLA-LTV

  4. FDA Approves Diet Drug to Treat Overweight Adults

    NEW YORK -- Some people who suffer from chronic weight issues may soon get some help from a pill.&#12288;
    CNN
    NEW YORK -- Some people who suffer from chronic weight issues may soon get some help from a pill.　 The U.S. Food and Drug Administration Wednesday approved Belviq, or lorcaserin hydrochloride, to be combined with a reduced-calorie diet and...

    Tags: Health, Obesity, Physical Fitness and Exercise, Heart Disease, Diabetes

    5. Jun 27, 2012 |Story| CNN

  5. FDA approves 1st new diet drug in 13 years

    SAN DIEGO -- The U.S. Food and Drug Administration Wednesday approved a new diet drug from San Diego's Arena Pharmaceuticals. It's the first diet drug approved in more than&nbsp; a decade.
    SAN DIEGO -- The U.S. Food and Drug Administration Wednesday approved a new diet drug from San Diego's Arena Pharmaceuticals. It's the first diet drug approved in more than  a decade. Belviq, or lorcaserin hydrochloride is to be combined with a reduced-...

    Tags: Health, Obesity, Physical Fitness and Exercise, Heart Disease, Overweight

    6. Sep 7, 2011 |Story| Reuters
  6. |Story

    Tags: Whole Foods Market, Justice System, Career and Workplace, Labor Markets, Laws

    7. Sep 15, 2010 |Story| Chicago Tribune

  7. Diet drugs face tough test

    There has never been a magic prescription to help millions of obese Americans lose weight. Whether one is any closer to reality is now under scrutiny.
    Tribune Newspapers
    There has never been a magic prescription to help millions of obese Americans lose weight. Whether one is any closer to reality is now under scrutiny. A Food and Drug Administration advisory panel will decide Wednesday whether the diet drug Meridia...

    Tags: Health Organizations, Health, Health and Medical Professionals, Obesity, Diabetes

    8. Oct 29, 2010 |Story| Associated Press

  8. FDA declines approval for Vivus diet drug Qnexa, despite significant weight loss in studies

    WASHINGTON (AP) &#8212; Federal health regulators have decided not to approve an experimental diet pill called Qnexa, which had been touted by many experts as the most promising weight-loss drug in more than a decade.
    AP Business Writer
    WASHINGTON (AP) — Federal health regulators have decided not to approve an experimental diet pill called Qnexa, which had been touted by many experts as the most promising weight-loss drug in more than a decade. The drug's maker, Vivus Inc., said...

    Tags: Health, Companies and Corporations, Health and Medical Professionals, Birth Defects, Obesity

    9. Sep 17, 2010 |Story| Los Angeles Times

  9. The scorecard on obesity drugs: 0 for 3

    This is not shaping up to be a good year for people seeking medical help for weight loss. A Food and Drug Administration advisory committee on Thursday voted against recommending approval of the drug lorcaserin. This is the third negative vote on prescription obesity drugs this year by the advisory committee.
    Los Angeles Times Staff Writer
    This is not shaping up to be a good year for people seeking medical help for weight loss. A Food and Drug Administration advisory committee on Thursday voted against recommending approval of the drug lorcaserin. This is the third negative vote on...

    Tags: Health, Health and Medical Professionals, Cancer, Obesity, Heart Disease

    10. Jul 12, 2010 |Story| Associated Press

  10. FDA to Review New Weight-Loss Drug

    WASHINGTON (AP) &#8212; Dieters, doctors and investors get their first extensive look at the first of a trio of new weight loss drugs this week. The hope is that the new drugs can succeed where many others have failed: delivering significant weight loss without risky side effects.
    AP Business Writer
    WASHINGTON (AP) — Dieters, doctors and investors get their first extensive look at the first of a trio of new weight loss drugs this week. The hope is that the new drugs can succeed where many others have failed: delivering significant weight loss...

    Tags: Crime, Law and Justice, Health, Companies and Corporations, Obesity, Sanofi-Aventis

    11. Jul 13, 2010 |Story| Associated Press

  11. Weight Loss Drug Faces FDA Questions

    Vivus Inc.'s experimental drug Qnexa was effective in cutting weight, the Food and Drug Administration said Tuesday, while acknowledging lingering concerns over the drug's nervous system and psychiatric side effects.
    Vivus Inc.'s experimental drug Qnexa was effective in cutting weight, the Food and Drug Administration said Tuesday, while acknowledging lingering concerns over the drug's nervous system and psychiatric side effects. Still, shares of Vivus jumped as...

    Tags: Health, Obesity, Vivus Inc., Weight Loss, Drugs and Medicines

    12. Jul 14, 2010 |Story| Associated Press

  12. Experimental Diet Pill Promising

    An experimental diet pill helped about half the people who tried it lose some weight and keep it off a year later, without the heart problems that some earlier drugs caused, a study found.
    The Associated Press
    An experimental diet pill helped about half the people who tried it lose some weight and keep it off a year later, without the heart problems that some earlier drugs caused, a study found. Arena Pharmaceuticals' lorcaserin is one of three drugs that...

    Tags: Health, Northwestern University, Obesity, Migraine, Heart Disease

 1  2 • Next >
Advertisement